Molecular image-guided surgery in gynaecological cancer: where do we stand?
Gynaecological cancers
Hybrid tracer
Image-guided surgery
Robotic surgery
Sentinel node biopsy
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
06
10
2023
accepted:
04
01
2024
medline:
18
1
2024
pubmed:
18
1
2024
entrez:
17
1
2024
Statut:
aheadofprint
Résumé
The aim of this review is to give an overview of the current status of molecular image-guided surgery in gynaecological malignancies, from both clinical and technological points of view. A narrative approach was taken to describe the relevant literature, focusing on clinical applications of molecular image-guided surgery in gynaecology, preoperative imaging as surgical roadmap, and intraoperative devices. The most common clinical application in gynaecology is sentinel node biopsy (SNB). Other promising approaches are receptor-target modalities and occult lesion localisation. Preoperative SPECT/CT and PET/CT permit a roadmap for adequate surgical planning. Intraoperative detection modalities span from 1D probes to 2D portable cameras and 3D freehand imaging. After successful application of radio-guided SNB and SPECT, innovation is leaning towards hybrid modalities, such as hybrid tracer and fusion of imaging approaches including SPECT/CT and PET/CT. Robotic surgery, as well as augmented reality and virtual reality techniques, is leading to application of these innovative technologies to the clinical setting, guiding surgeons towards a precise, personalised, and minimally invasive approach.
Identifiants
pubmed: 38233609
doi: 10.1007/s00259-024-06604-1
pii: 10.1007/s00259-024-06604-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Wendler T, van Leeuwen FWB, Navab N, van Oosterom MN. How molecular imaging will enable robotic precision surgery: the role of artificial intelligence, augmented reality, and navigation. Eur J Nucl Med Mol Imaging. 2021;48:4201–24.
pubmed: 34185136
pmcid: 8566413
van Leeuwen FWB, Schottelius M, Brouwer OR, Vidal-Sicart S, Achilefu S, Klode J, et al. Trending: radioactive and fluorescent bimodal/hybrid tracers as multiplexing solutions for surgical guidance. J Nucl Med. 2020;61:13–9.
pubmed: 31712326
Valdés Olmos RA, Rietbergen DDD, Rubello D, Pereira Arias-Bouda LM, Collarino A, Colletti PM, et al. Sentinel node imaging and radioguided surgery in the era of SPECT/CT and PET/CT: toward new interventional nuclear medicine strategies. Clin Nucl Med. 2020;45:771–7.
pubmed: 32701805
Giammarile F, Bozkurt MF, Cibula D, Pahisa J, Oyen WJ, Paredes P, et al. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging. 2014;41:1463–77.
pubmed: 24609929
Oonk MHM, van de Nieuwenhof HP, de Hullu JA, van der Zee AGJ. The role of sentinel node biopsy in gynecological cancer: a review. Curr Opin Oncol. 2009;21:425–32.
pubmed: 19593136
Collarino A, Fuoco V, Garganese G, Pereira Arias-Bouda LM, Perotti G, Manca G, et al. Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel. Eur J Nucl Med Mol Imaging. 2020;47:1261–74.
pubmed: 31897584
Van Oosterom MN, Rietbergen DDD, Welling MM, Van Der Poel HG, Maurer T, Van Leeuwen FWB. Recent advances in nuclear and hybrid detection modalities for image-guided surgery. Expert Rev Med Devices. 2019;16:711–34.
pubmed: 31287715
Crane LMA, Themelis G, Arts HJG, Buddingh KT, Brouwers AH, Ntziachristos V, et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol. 2011;120:291–5.
pubmed: 21056907
Meershoek P, van Oosterom MN, Simon H, Mengus L, Maurer T, van Leeuwen PJ, et al. Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation. Eur J Nucl Med Mol Imaging. 2019;46:49–53.
pubmed: 30054696
Meads C, Sutton AJ, Rosenthal AN, Małysiak S, Kowalska M, Zapalska A, et al. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer. 2014;110:2837–46.
pubmed: 24867697
pmcid: 4056048
Kadkhodayan S, Hasanzadeh M, Treglia G, Azad A, Yousefi Z, Zarifmahmoudi L, et al. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur J Surg Oncol. 2015;41:1–20.
pubmed: 25454828
Vera DR, Wallace AM, Hoh CK, Mattrey RF. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med. 2001;42:951–9.
pubmed: 11390562
Rovera G, de Koster EJ, Rufini V, Zollino M, Zagaria L, Giammarile F, et al. 99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel. Eur J Nucl Med Mol Imaging. 2023;50:3375–89.
pubmed: 37310426
Mueller JJ, Dauer LT, Murali R, Iasonos A, Pandit-Taskar N, Abu-Rustum NR, et al. Positron lymphography via intracervical 18F-FDG injection for presurgical lymphatic mapping in cervical and endometrial malignancies. J Nucl Med. 2020;61:1123–30.
pubmed: 31924717
pmcid: 7413230
Garganese G, Bove S, Fragomeni S, Moro F, Triumbari EKA, Collarino A, et al. Real-time ultrasound virtual navigation in 3D PET/CT volumes for superficial lymph-node evaluation: innovative fusion examination. Ultrasound Obstet Gynecol. 2021;58:766–72.
pubmed: 33587289
Manny TB, Patel M, Hemal AK. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur Urol. 2014;65:1162–8.
pubmed: 24289911
van Oosterom MN, Meershoek P, Welling MM, Pinto F, Matthies P, Simon H, et al. Extending the hybrid surgical guidance concept with freehand fluorescence tomography. IEEE Trans Med Imaging. 2020;39:226–35.
pubmed: 31247546
Schouw HM, Huisman LA, Janssen YF, Slart RHJA, Borra RJH, Willemsen ATM, et al. Targeted optical fluorescence imaging: a meta-narrative review and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48:4272–92.
pubmed: 34633509
pmcid: 8566445
Raimondo D, Borghese G, Mabrouk M, Arena A, Ambrosio M, Del Forno S, et al. Use of indocyanine green for intraoperative perfusion assessment in women with ureteral endometriosis: a preliminary study. J Minim Invasive Gynecol. 2021;28:42–9.
pubmed: 32283326
He K, Li P, Zhang Z, Liu J, Liu P, Gong S, et al. Intraoperative near-infrared fluorescence imaging can identify pelvic nerves in patients with cervical cancer in real time during radical hysterectomy. Eur J Nucl Med Mol Imaging. 2022;49:2929–37.
pubmed: 35230489
pmcid: 9206623
Doyle PJ, Lipetskaia L, Duecy E, Buchsbaum G, Wood RW. Sodium fluorescein use during intraoperative cystoscopy. Obstet Gynecol. 2015;125:548–50.
pubmed: 25730214
Cabanes M, Boria F, Hernández Gutiérrez A, Zapardiel I. Intra-operative identification of ureters using indocyanine green for gynecological oncology procedures. Int J Gynecol Cancer. 2020;30:278.
pubmed: 31722965
Moukarzel LA, Byrne ME, Leiva S, Wu M, Zhou QC, Iasonos A, et al. The impact of near-infrared angiography and proctoscopy after rectosigmoid resection and anastomosis performed during surgeries for gynecologic malignancies. Gynecol Oncol. 2020;158:397–401.
pubmed: 32460995
pmcid: 7693678
Bizzarri N, Foschi N, Loverro M, Tortorella L, Santullo F, Rosati A, et al. Indocyanine green to assess vascularity of ileal conduit anastomosis during pelvic exenteration for recurrent/persistent gynecological cancer: a pilot study. Front Oncol. 2021;11: 727725.
pubmed: 34950574
pmcid: 8691262
Buckle T, van Leeuwen AC, Chin PTK, Janssen H, Muller SH, Jonkers J, et al. A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node. Nanotechnology. 2010;21: 355101.
pubmed: 20689167
KleinJan GH, van Werkhoven E, van den Berg NS, Karakullukcu MB, Zijlmans HJM a. A, van der Hage JA, et al. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes. Eur J Nucl Med Mol Imaging. 2018;45:1915–25.
Paredes P, Vidal-Sicart S, Campos F, Tapias A, Sánchez N, Martínez S, et al. Role of ICG-99mTc-nanocolloid for sentinel lymph node detection in cervical cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2017;44:1853–61.
pubmed: 28492965
Sánchez-Izquierdo N, Vidal-Sicart S, Campos F, Torné A, Angeles MA, Migliorelli F, et al. Detection of the sentinel lymph node with hybrid tracer (ICG-[99mTc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study. EJNMMI Res. 2021;11:123.
pubmed: 34905122
pmcid: 8671586
Mathéron HM, van den Berg NS, Brouwer OR, Kleinjan GH, van Driel WJ, Trum JW, et al. Multimodal surgical guidance towards the sentinel node in vulvar cancer. Gynecol Oncol. 2013;131:720–5.
pubmed: 24051219
Emerson DK, Limmer KK, Hall DJ, Han S-H, Eckelman WC, Kane CJ, et al. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012;265:186–93.
pubmed: 22753678
pmcid: 3447170
Minamiya Y, Ito M, Katayose Y, Saito H, Imai K, Sato Y, et al. Intraoperative sentinel lymph node mapping using a new sterilizable magnetometer in patients with nonsmall cell lung cancer. Ann Thorac Surg. 2006;81:327–30.
pubmed: 16368392
Murakami K, Kotani Y, Suzuki A, Takaya H, Nakai H, Matsuki M, et al. Superparamagnetic iron oxide as a tracer for sentinel lymph node detection in uterine cancer: a pilot study. Sci Rep. 2020;10:7945.
pubmed: 32409660
pmcid: 7224276
Jedryka MA, Klimczak P, Kryszpin M, Matkowski R. Superparamagnetic iron oxide: a novel tracer for sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer. 2020;30:1280–4.
pubmed: 32675253
Wang YN, Xia YF, Chen YQ, Qi HY, Lou YH. Application of the two-step sentinel lymph node biopsy with double-tracer in early staged endometrial cancer. Zhonghua Fu Chan Ke Za Zhi. 2022;57:812–20.
pubmed: 36456477
Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327–34.
pubmed: 7774836
Ho C-M, Chien T-Y, Huang S-H, Wu C-J, Shih B-Y, Chang S-C. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol. 2004;93:458–64.
pubmed: 15099962
Winer I, Ahmed QF, Mert I, Bandyopadhyay S, Cote M, Munkarah AR, et al. Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence? Int J Gynecol Pathol. 2015;34:47–56.
pubmed: 25473753
National Comprehensive Cancer Network. (2023). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): uterine neoplasms (Version 1.2024). https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf . Accessed Oct 2023
Collarino A, Donswijk ML, van Driel WJ, Stokkel MP, Valdés Olmos RA. The use of SPECT/CT for anatomical mapping of lymphatic drainage in vulvar cancer: possible implications for the extent of inguinal lymph node dissection. Eur J Nucl Med Mol Imaging. 2015;42:2064–71.
pubmed: 26219869
Collarino A, Vidal-Sicart S, Perotti G, Valdés Olmos RA. The sentinel node approach in gynaecological malignancies. Clin Transl Imaging. 2016;4:411–20.
pubmed: 27738629
pmcid: 5037154
National Comprehensive Cancer Network. (2023). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Vulvar Cancer (Version 1.2024). https://www.nccn.org/professionals/physician_gls/pdf/vulvar.pdf . Accessed Oct 2023
Oonk MHM, Planchamp F, Baldwin P, Mahner S, Mirza MR, Fischerová D, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. Int J Gynecol Cancer. 2023;33:1023–43.
pubmed: 37369376
pmcid: 10359596
Collarino A, Fuoco V, Garganese G, Pasciuto T, de Koster EJ, Florit A, et al. Lymphatic mapping and sentinel node biopsy in vulvar melanoma: the first multicenter study and systematic review. Gynecol Oncol. 2023;170:153–9.
pubmed: 36696819
Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30:3786–91.
pubmed: 22753905
pmcid: 3478573
Van der Zee AGJ, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.
pubmed: 18281661
Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11:646–52.
pubmed: 20537946
Te Grootenhuis NC, van der Zee AGJ, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140:8–14.
Garganese G, Collarino A, Fragomeni SM, Rufini V, Perotti G, Gentileschi S, et al. Groin sentinel node biopsy and 18F-FDG PET/CT-supported preoperative lymph node assessment in cN0 patients with vulvar cancer currently unfit for minimally invasive inguinal surgery: The GroSNaPET study. Eur J Surg Oncol. 2017;43:1776–83.
pubmed: 28751058
Collarino A, Garganese G, Valdés Olmos RA, Stefanelli A, Perotti G, Mirk P, et al. Evaluation of dual-timepoint 18F-FDG PET/CT imaging for lymph node staging in vulvar cancer. J Nucl Med. 2017;58:1913–8.
pubmed: 28546331
Koual M, Benoit L, Nguyen-Xuan H-T, Bentivegna E, Azaïs H, Bats A-S. Diagnostic value of indocyanine green fluorescence guided sentinel lymph node biopsy in vulvar cancer: A systematic review. Gynecol Oncol. 2021;161:436–41.
pubmed: 33551201
Verbeek FPR, Tummers QRJG, Rietbergen DDD, Peters AAW, Schaafsma BE, van de Velde CJH, et al. Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. Int J Gynecol Cancer. 2015;25:1086–93.
pubmed: 25768079
pmcid: 4478233
Deken MM, van Doorn HC, Verver D, Boogerd LSF, de Valk KS, Rietbergen DDD, et al. Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial. Gynecol Oncol. 2020;159:672–80.
pubmed: 33041071
Benedetti-Panici P, Maneschi F, Scambia G, Greggi S, Cutillo G, D’Andrea G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19–24.
pubmed: 8690286
National Comprehensive Cancer Network. (2023). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Cervical Cancer (Version 1.2024). https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf . Accessed Oct 2023
Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. Int J Gynecol Cancer. 2023;33:649–66.
pubmed: 37127326
pmcid: 10176411
Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29:1686–91.
pubmed: 21444878
Bats A-S, Buénerd A, Querleu D, Leblanc E, Daraï E, Morice P, et al. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol. 2011;123:230–5.
pubmed: 21893335
Bats A-S, Mathevet P, Buenerd A, Orliaguet I, Mery E, Zerdoud S, et al. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol. 2013;20:413–22.
pubmed: 22911367
Mathevet P, Lécuru F, Uzan C, Boutitie F, Magaud L, Guyon F, et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer. 2021;148:307–15.
pubmed: 33773275
Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018;19:1394–403.
pubmed: 30143441
pmcid: 6580418
Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2018;143:37–50.
pubmed: 30306580
Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31:12–39.
pubmed: 33397713
Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.
pubmed: 21489874
Cusimano MC, Vicus D, Pulman K, Maganti M, Bernardini MQ, Bouchard-Fortier G, et al. Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surg. 2021;156:157–64.
pubmed: 33175109
McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology. 2005;47:231–47.
pubmed: 16115224
Fournier M, Stoeckle E, Guyon F, Brouste V, Thomas L, MacGrogan G, et al. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients. Int J Gynecol Cancer. 2009;19:1307–13.
pubmed: 20009882
Yu H, Wang J, Wu B, Li J, Chen R. Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis. J Ovarian Res. 2023;16:28.
pubmed: 36717897
pmcid: 9885671
Hassanzadeh M, Hosseini Farahabadi E, Yousefi Z, Kadkhodayan S, Zarifmahmoudi L, Sadeghi R. Lymphatic mapping and sentinel node biopsy in ovarian tumors: a study using intra-operative Tc-99m-Phytate and lymphoscintigraphy imaging. J Ovarian Res. 2016;9:55.
pubmed: 27604260
pmcid: 5013627
Speth SCJM, Kruitwagen RFPM, Kleppe M, Pooters INA, Van Gorp T, Slangen BFM, et al. Comparison of intraoperative γ-probe imaging and postoperative SPECT/CT in detection of sentinel nodes related to the ovary. J Nucl Med. 2017;58:243–5.
pubmed: 27738006
Nyberg RH, Korkola P, Mäenpää JU. Sentinel node and ovarian tumors: a series of 20 patients. Int J Gynecol Cancer. 2017;27:684–9.
pubmed: 28375928
Kleppe M, Brans B, Van Gorp T, Slangen BFM, Kruse AJ, Pooters INA, et al. The detection of sentinel nodes in ovarian cancer: a feasibility study. J Nucl Med. 2014;55:1799–804.
pubmed: 25332439
Lago V, Bello P, Montero B, Matute L, Padilla-Iserte P, Lopez S, et al. Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study. Int J Gynecol Cancer. 2019;29:377–81.
pubmed: 30718316
Lago V, Bello P, Montero B, Matute L, Padilla-Iserte P, Lopez S, et al. Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial. Int J Gynecol Cancer. 2020;30:1390–6.
pubmed: 32448808
pmcid: 7497563
Scambia G, Nero C, Uccella S, Vizza E, Ghezzi F, Cosentino F, et al. Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY). Int J Gynecol Cancer. 2019;29:1437–9.
pubmed: 31601646
Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, et al. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol. 2017;14:347–64.
pubmed: 28094261
pmcid: 5683405
Kalli KR, Oberg AL, Keeney GL, Christianson TJH, Low PS, Knutson KL, et al. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol. 2008;108:619–26.
pubmed: 18222534
pmcid: 2707764
O’Shannessy DJ, Somers EB, Smale R, Fu Y-S. Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor type. Int J Gynecol Pathol. 2013;32:258–68.
pubmed: 23518909
van Dam GM, Themelis G, Crane LMA, Harlaar NJ, Pleijhuis RG, Kelder W, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med. 2011;17:1315–9.
pubmed: 21926976
Tummers QRJG, Hoogstins CES, Gaarenstroom KN, de Kroon CD, van Poelgeest MIE, Vuyk J, et al. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Oncotarget. 2016;7:32144–55.
pubmed: 27014973
pmcid: 5078003
Hoogstins CES, Tummers QRJG, Gaarenstroom KN, de Kroon CD, Trimbos JBMZ, Bosse T, et al. A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer. Clin Cancer Res. 2016;22:2929–38.
pubmed: 27306792
Boogerd LSF, Hoogstins CES, Gaarenstroom KN, de Kroon CD, Beltman JJ, Bosse T, et al. Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study. Oncotarget. 2017;9:791–801.
pubmed: 29416655
pmcid: 5787511
Randall LM, Wenham RM, Low PS, Dowdy SC, Tanyi JL. A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer. Gynecol Oncol. 2019;155:63–8.
pubmed: 31362825
Tanyi JL, Randall LM, Chambers SK, Butler KA, Winer IS, Langstraat CL, et al. A phase III study of pafolacianine injection (OTL38) for intraoperative imaging of folate receptor-positive ovarian cancer (Study 006). J Clin Oncol. 2023;41:276–84.
pubmed: 36070540
Müller C. Folate-based radiotracers for PET imaging—update and perspectives. Molecules. 2013;18:5005–31.
pubmed: 23629756
pmcid: 6269920
Siegel BA, Dehdashti F, Mutch DG, Podoloff DA, Wendt R, Sutton GP, et al. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nucl Med. 2003;44:700–7.
pubmed: 12732670
Fisher RE, Siegel BA, Edell SL, Oyesiku NM, Morgenstern DE, Messmann RA, et al. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med. 2008;49:899–906.
pubmed: 18483093
Hekman MCH, Boerman OC, Bos DL, Massuger LFAG, Weil S, Grasso L, et al. Improved intraoperative detection of ovarian cancer by folate receptor alpha targeted dual-modality imaging. Mol Pharm. 2017;14:3457–63.
pubmed: 28826214
pmcid: 6150714
Dauphine C, Reicher JJ, Reicher MA, Gondusky C, Khalkhali I, Kim M. A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology. AJR Am J Roentgenol. 2015;204:W720–3.
pubmed: 26001262
Constantinidis F, Sakellariou S, Chang SL, Linder S, MacPherson B, Seth S, et al. Wireless localisation of breast lesions with MagSeed. A radiological perspective of 300 cases. Br J Radiol. 2022;95:20211241.
pubmed: 35201906
Manca G, Garau LM, Romanini A, Rubello D, Nuzzo A, Barbarello L, et al. Detection of uterine leiomyosarcoma peritoneal lesions by SPECT/CT and ROLL technique. Clin Nucl Med. 2019;44:826–8.
pubmed: 31306202
Garner HW, Bestic JM, Peterson JJ, Attia S, Wessell DE. Preoperative radioactive seed localization of nonpalpable soft tissue masses: an established localization technique with a new application. Skeletal Radiol. 2017;46:209–16.
pubmed: 27885379
Hassing CMS, Tvedskov TF, Kroman N, Klausen TL, Drejøe JB, Tvedskov JF, et al. Radioactive seed localisation of non-palpable lymph nodes - A feasibility study. Eur J Surg Oncol. 2018;44:725–30.
pubmed: 29545086
Beneder C, Fuechsel FG, Krause T, Kuhn A, Mueller MD. The role of 3D fusion imaging in sentinel lymphadenectomy for vulvar cancer. Gynecol Oncol. 2008;109:76–80.
pubmed: 18215758
Valdés Olmos RA, Rietbergen DD, Vidal-Sicart S, Manca G, Giammarile F, Mariani G. Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from “open and see” to “see and open.” Q J Nucl Med Mol Imaging. 2014;58:127–39.
pubmed: 24835289
Klapdor R, Länger F, Gratz KF, Hillemanns P, Hertel H. SPECT/CT for SLN dissection in vulvar cancer: Improved SLN detection and dissection by preoperative three-dimensional anatomical localisation. Gynecol Oncol. 2015;138:590–6.
pubmed: 26067332
Navarro A-S, Angeles MA, Migliorelli F, Illac C, Martínez-Gómez C, Leray H, et al. Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies. Int J Gynecol Cancer. 2021;31:679–85.
pubmed: 33649157
Hoogendam JP, Veldhuis WB, Hobbelink MGG, Verheijen RHM, van den Bosch MAAJ, Zweemer RP. 99mTc SPECT/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and metaanalysis. J Nucl Med. 2015;56:675–80.
pubmed: 25858041
Martínez A, Zerdoud S, Mery E, Bouissou E, Ferron G, Querleu D. Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix. Gynecol Oncol. 2010;119:431–5.
pubmed: 20822803
Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol. 2010;117:59–64.
pubmed: 20117827
Buda A, Elisei F, Arosio M, Dolci C, Signorelli M, Perego P, et al. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. Int J Gynecol Cancer. 2012;22:830–5.
pubmed: 22617479
Garganese G, Bove S, Zagaria L, Moro F, Fragomeni SM, Ieria FP, et al. Fusion of ultrasound and 3D single-photon-emission computed tomography/computed tomography to identify sentinel lymph nodes in vulvar cancer: feasibility study. Ultrasound Obstet Gynecol. 2019;54:545–51.
pubmed: 31152573
Narayanan P, Sahdev A. The role of 18F-FDG PET CT in common gynaecological malignancies. Br J Radiol. 2017;90:20170283.
pubmed: 28830238
pmcid: 5963379
Crivellaro C, Signorelli M, Guerra L, De Ponti E, Buda A, Dolci C, et al. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer. Gynecol Oncol. 2012;127:131–5.
pubmed: 22772064
Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, et al. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol. 2013;130:306–11.
pubmed: 23707673
Aide N, Markovina S, Ferrero A. Is it time to include [18F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients? Eur J Nucl Med Mol Imaging. 2021;48:3043–5.
pubmed: 33768280
Triumbari EKA, de Koster EJ, Rufini V, Fragomeni SM, Garganese G, Collarino A. 18F-FDG PET and 18F-FDG PET/CT in vulvar cancer: a systematic review and meta-analysis. Clin Nucl Med. 2021;46:125–32.
pubmed: 33234921
Rufini V, Garganese G, Ieria FP, Pasciuto T, Fragomeni SM, Gui B, et al. Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study. Eur J Nucl Med Mol Imaging. 2021;48:3303–14.
pubmed: 33619601
pmcid: 8426310
Dendl K, Koerber SA, Finck R, Mokoala KMG, Staudinger F, Schillings L, et al. 68Ga-FAPI-PET/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021;48:4089–100.
pubmed: 34050777
pmcid: 8484099
Chen J, Xu K, Li C, Tian Y, Li L, Wen B, et al. [68Ga]Ga-FAPI-04 PET/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2023;50:4064–76.
pubmed: 37526694
Decesare SL, Fiorica JV, Roberts WS, Reintgen D, Arango H, Hoffman MS, et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol. 1997;66:425–8.
pubmed: 9299256
de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med. 1998;39:1381–5.
pubmed: 9708512
Schneebaum S, Even-Sapir E, Cohen M, Shacham-Lehrman H, Gat A, Brazovsky E, et al. Clinical applications of gamma-detection probes - radioguided surgery. Eur J Nucl Med. 1999;26:S26-35.
pubmed: 10199930
Holman LL, Levenback CF, Frumovitz M. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014;21:540–5.
pubmed: 24407177
pmcid: 4283488
Povoski SP, Hall NC, Murrey DA, Chow AZ, Gaglani JR, Bahnson EE, et al. Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience. World J Surg Oncol. 2011;9:152.
pubmed: 22112047
pmcid: 3247132
Yen T-C, See L-C, Lai C-H, Yah-Huei CW, Ng K-K, Ma S-Y, et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med. 2004;45:22–9.
pubmed: 14734665
Collarino A, Florit A, Bizzarri N, Lanni V, Morganti S, De Summa M, et al. Radioguided surgery with β decay: a feasibility study in cervical cancer. Phys Med. 2023;113: 102658.
pubmed: 37603908
Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S. Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med. 1998;25:1224–31.
pubmed: 9724369
Dell’Oglio P, Meershoek P, Maurer T, Wit EMK, van Leeuwen PJ, van der Poel HG, et al. A DROP-IN gamma probe for robot-assisted radioguided surgery of lymph nodes during radical prostatectomy. Eur Urol. 2021;79:124–32.
pubmed: 33203549
Baeten IGT, Hoogendam JP, Braat AJAT, Zweemer RP, Gerestein CG. Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer. EJNMMI Res. 2022;12:36.
pubmed: 35723832
pmcid: 9209631
Fuerst B, Sprung J, Pinto F, Frisch B, Wendler T, Simon H, et al. First robotic SPECT for minimally invasive sentinel lymph node mapping. IEEE Trans Med Imaging. 2016;35:830–8.
pubmed: 26561283
Azargoshasb S, Houwing KHM, Roos PR, van Leeuwen SI, Boonekamp M, Mazzone E, et al. Optical navigation of the drop-in γ-probe as a means to strengthen the connection between robot-assisted and radioguided surgery. J Nucl Med. 2021;62:1314–7.
pubmed: 33419942
pmcid: 8882900
Azargoshasb S, van Alphen S, Slof LJ, Rosiello G, Puliatti S, van Leeuwen SI, et al. The Click-On gamma probe, a second-generation tethered robotic gamma probe that improves dexterity and surgical decision-making. Eur J Nucl Med Mol Imaging. 2021;48:4142–51.
pubmed: 34031721
pmcid: 8566398
Vidal-Sicart S, Seva A, Campos F, Sánchez N, Alonso I, Pahisa J, et al. Clinical use of an opto-nuclear probe for hybrid sentinel node biopsy guidance: first results. Int J Comput Assist Radiol Surg. 2019;14:409–16.
pubmed: 29968113
Ookubo T, Inoue Y, Kim D, Ohsaki H, Mashiko Y, Kusakabe M, et al. Characteristics of magnetic probes for identifying sentinel lymph nodes. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:5485–8.
pubmed: 24110978
Douek M, Klaase J, Monypenny I, Kothari A, Zechmeister K, Brown D, et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol. 2014;21:1237–45.
pubmed: 24322530
van den Berg NS, Simon H, Kleinjan GH, Engelen T, Bunschoten A, Welling MM, et al. First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery. Eur J Nucl Med Mol Imaging. 2015;42:1639–47.
pubmed: 26109329
Olmos RAV, Vidal-Sicart S, Nieweg OE. SPECT-CT and real-time intraoperative imaging: new tools for sentinel node localization and radioguided surgery? Eur J Nucl Med Mol Imaging. 2009;36:1–5.
pubmed: 18931842
Vidal-Sicart S, Vermeeren L, Solà O, Paredes P, Valdés-Olmos RA. The use of a portable gamma camera for preoperative lymphatic mapping: a comparison with a conventional gamma camera. Eur J Nucl Med Mol Imaging. 2011;38:636–41.
pubmed: 21174091
Heller S, Zanzonico P. Nuclear probes and intraoperative gamma cameras. Semin Nucl Med. 2011;41:166–81.
pubmed: 21440694
Markus A, Ray ASC, Bolla D, Müller J, Diener P-A, Wendler T, et al. Sentinel lymph node biopsy in endometrial and cervical cancers using freehand SPECT—first experiences. Gynecol Surg. 2016;13:499–506.
Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, et al. Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes. Eur J Nucl Med Mol Imaging. 2016;43:2304–12.
pubmed: 27311920
Azargoshasb S, Molenaar L, Rosiello G, Buckle T, van Willigen DM, van de Loosdrecht MM, et al. Advancing intraoperative magnetic tracing using 3D freehand magnetic particle imaging. Int J Comput Assist Radiol Surg. 2022;17:211–8.
pubmed: 34333740
Wendler T, Traub J, Ziegler SI, Navab N. Navigated three dimensional beta probe for optimal cancer resection. Med Image Comput Comput Assist Interv. 2006;9:561–9.
pubmed: 17354935
Togami S, Fukuda M, Mizuno M, Yanazume S, Kobayashi H. Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer. J Gynecol Oncol. 2023;34: e68.
pubmed: 37293801
pmcid: 10627747
Mohammad A, Hunter MI. Robot-assisted sentinel lymph node mapping and inguinal lymph node dissection using near-infrared dluorescence in vulvar cancer. J Minim Invasive Gynecol. 2019;26:968–72.
pubmed: 30959199
Baeten IGT, Hoogendam JP, Braat AJAT, de Keizer B, Gerestein CG, Zweemer RP. Learning curve and factors influencing successful robot-assisted bilateral sentinel lymph node mapping in early-stage cervical cancer: an observational cohort study. Expert Rev Med Devices. 2023;20:589–96.
pubmed: 37278067
Andras I, Mazzone E, van Leeuwen FWB, De Naeyer G, van Oosterom MN, Beato S, et al. Artificial intelligence and robotics: a combination that is changing the operating room. World J Urol. 2020;38:2359–66.
pubmed: 31776737
Bourdel N, Collins T, Pizarro D, Debize C, Grémeau A-S, Bartoli A, et al. Use of augmented reality in laparoscopic gynecology to visualize myomas. Fertil Steril. 2017;107:737–9.
pubmed: 28089570
Lecointre L, Verde J, Hubele F, Salvadori J, Goffin L, Akladios C, et al. Preoperative SPECT/CT + intraoperative CT fusion enabling surgical augmented reality to target sentinel lymph node in endometrial cancer. EJNMMI Phys. 2022;9:81.
pubmed: 36414716
pmcid: 9681940